National Comprehensive Cancer Network Expert Discusses Extending Life-Saving Pediatric Treatments to Adults with Acute Lymphoblastic Leukemia

FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children; however with improvements in treatments, approximately 80 percent of young patients can be cured from the disease. There has been increasing interest in extending pediatric regimens to adult populations, but challenges remain noted Daniel J. DeAngelo, MD, of Dana-Farber Cancer Institute and an expert panel member of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for ALL. The impact of age in the selection of treatment for ALL was the center of a presentation given by Dr. DeAngelo at the recent NCCN 6th Annual Congress: Hematologic Malignancies™.

Back to news